VTI - Vanguard Total Stock Market ETF
| Previous Close | 144.29 |
| Open | 143.85 |
| Bid | 0.00 x 1200 |
| Ask | 0.00 x 800 |
| Day's Range | 143.23 - 144.33 |
| 52 Week Range | 123.48 - 146.87 |
| Volume | 3,328,544 |
| Avg. Volume | 2,264,426 |
| Net Assets | 698.64B |
| NAV | 140.03 |
| PE Ratio (TTM) | N/A |
| Yield | 1.69% |
| YTD Return | 2.46% |
| Beta (3y) | 1.00 |
| Expense Ratio (net) | 0.04% |
| Inception Date | 2001-05-24 |
- MarketWatch•2 days ago
Wealth management secrets that beat the Ivy League
It’s not rocket scienceMary Evans/BUENA VISTA/Ronald Grant/Everett CollectionSometimes the Ivy League gets it wrong. In the 10 years ending June 2017, that manager — a former beer company executive named Bill Abt — simply slayed the big, fancy endowments, including Harvard. In fact, Abt’s investments in market-tracking index funds from Vanguard beat 90% of college endowments, returning 6.2% annually.
- Investopedia•11 days ago
Top 3 ETFs for Long-Term Investors as of June 2018
Are you the sort of investor who embraces the buy-and-hold strategy, preferring to do your due diligence up front and then let the returns accumulate over time? In fact, he made a point of requesting that 90% of the money he leaves his wife when he dies be invested in an S&P 500 index fund. Of course, you don't have to park all your money in an S&P 500 fund. In fact, most experts recommend some diversification.
- Market Realist•18 days ago
Understanding the Trend in American Express’s Total Expenses
American Express (AXP) incurred total expenses amounting to $6.9 billion in the first quarter, implying a rise of 9% on a YoY (year-over-year) basis. The company incurred marketing and business-development expenses amounting to $1.34 billion in Q1 2018 compared to $1.28 billion in Q1 2017, reflecting a rise of 5%. Amex incurred cardmember rewards expenses amounting to $2.34 billion in Q1 2018 compared to $2.06 billion in Q1 2017, reflecting a rise of 14% YoY.
- Motley Fool•28 days ago
3 Top Index Funds to Keep You in the Investing Game
A few great places to park your cash when you'd rather not direct it toward a single stock.
- Bloomberg•last month
Meet the Portfolio Manager Overseeing $1 Trillion
Gerry O'Reilly, Vanguard principal and portfolio manager, oversees more than $1 trillion in 16 of the firm’s biggest funds. O'Reilly speaks with Bloomberg's Scarlet Fu and Eric Balchunas about the Vanguard ...
- Benzinga•last month
More Than The Core: Some Focused ETFs Gather Big Cash
Most of the time, exchange traded funds adding the most assets qualify as plain vanilla funds, or those funds that can be used as “core” holdings. Think traditional S&P 500 tracking funds or products like the Vanguard Total Market ETF (NYSE: VTI) and the iShares Core MSCI EAFE ETF (CBOE:IEFA). “More than a third of the way through 2018, investors have poured $93 billion into ETFs,” said CFRA Research Director of ETF & Mutual Fund Research Todd Rosenbluth in a Monday note.
- Investopedia•last month
Tools for Developing an ETF Portfolio in 2018
As exchange-traded funds (ETFs) have grown more popular among investors of all types, they have also become increasingly confusing and complicated. Particularly for those investors looking to invest in ETFs for the first time, it can be difficult to determine the best way to do so. Currently, there are close to 2,000 ETFs available to investors, covering a total of roughly $3 trillion in assets.
- InvestorPlace•last month
3 Reasons To Like PowerShares QQQ Trust, Series 1 (ETF)
The PowerShares QQQ Trust, Series 1 (ETF) (NASDAQ:QQQ) — an ETF (Exchange Traded Fund) that tracks 100 of the largest U.S. and international non-financial stocks listed on the NASDAQ Index — has been a mixed bag this year.7 Cheap Stocks With Strong Technical Signals
- InvestorPlace•2 months ago
7 Really, Really Cheap ETFs
There is no doubt about it. Passively managed index funds and exchange-traded funds (ETFs) are driving fund industry fees lower while saving investors billions of dollars in the process. Last year, investors paid record low fees, saving a tidy $4 billion along the way.
- Morningstar•2 months ago
3 ETF Retirement Saver Portfolios for Taxable Accounts
Composed of broad-market equity ETFs and smaller allocations to municipal bonds, these portfolios are designed for retirement savers' taxable accounts.
- Forbes•2 months ago
Investment Strategies To Improve On Passive U.S. Indexing
For many, passive indexing against a robust U.S. index is a sound strategy. But academic research suggests there may be a view ways to improve risk-adjusted returns beyond this. We explore implementing these strategies with popular ETFs.
- Investopedia•2 months ago
Top 3 ETFs for Long-Term Investors as of March 2018
Long-term investors may find these buy-and-hold ETFs very appealing.
- Market Realist•3 months ago
Equity ETFs Witnessed Net Outflows Last Week
Financials Had Solid Gains on March 26–29
- Forbes•3 months ago
4 Other Ways To Time The Market
Market timing is generally agreed to be extremely challenging. Yet seasonal factors do persist in the market over time and could offer you a slight edge when buying or selling.
- Investopedia•4 months ago
Top 3 ETFs for Long-Term Investors as of February 2018
Long-term investors may find these buy-and-hold ETFs very appealing.
- Forbes•4 months ago
Live Well While The Market Tanks
A spending formula to protect you in retirement from panic and from penury.
Market Realist•4 months agoA Deep Look at Globus Medical’s Financial Performance
Here's What's in Store for Globus Medical in 2018
Market Realist•4 months agoHow Did Orkambi Perform in 4Q17 and 2017?
How Is Vertex Pharmaceuticals Positioned after 4Q17? In 4Q17, Vertex Pharmaceuticals’ (VRTX) Orkambi generated revenues of $365 million, which reflected ~32% growth on a year-over-year (or YoY) basis and 9% growth on a quarter-over-quarter (or QoQ) basis. In fiscal 2017, Orkambi generated revenues of $1.3 billion, a ~35% increase on a YoY basis.
Market Realist•4 months agoBiogen: How It Performed in 4Q17
Biogen: How It Performed in 4Q17Biogen’s revenue trends
Market Realist•4 months agoAbbott Laboratories on the Street: Analyst Recommendations after the 4Q17 Results
What's Next for Abbott Laboratories after a Stellar 2017?
- Market Realist•5 months ago
What Else Could Drive Gilead’s Long-Term Growth?
Where's Gilead Sciences Now? Key January Updates
- Market Realist•5 months ago
What Does Mexico’s Manufacturing PMI Indicate?
A Look at Emerging Market December PMI Reports
- Morningstar•5 months ago
An Aggressive ETF Bucket Portfolio for Retirement
This ETF-oriented portfolio is ideal for retirees with long time horizons.
- Bloomberg Video•last month
Meet the Portfolio Manager Overseeing $1 Trillion
May.16 -- Gerry O'Reilly, Vanguard principal and portfolio manager, oversees more than $1 trillion in 16 of the firm’s biggest funds. O'Reilly speaks with Bloomberg's Scarlet Fu and Eric Balchunas about the Vanguard Total Stock Market ETF (ticker: VTI), low fees and the "art of passive management."
